Scott Biller, Chief Scientific Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 4,292 shares at $67.23 ($289K) on 2017-10-02, disclosed to the SEC on 2017-10-04.
Seasonal sale ($289k) by Chief Scientific Officer — this insider has traded AGIO in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.23 | 955 | $64K | 22.3% |
| 2 | $67.23 | 955 | $64K | 22.3% |
| 3 | $67.23 | 1,191 | $80K | 27.7% |
| 4 | $67.23 | 1,191 | $80K | 27.7% |
| Total | $67.23 avg | 4,292 | $289K | 100% |
| Filing → |
| AGIO | SELL | 2019-03-01 | $585K | — | Filing → |
| AGIO | SELL | 2018-11-07 | $209K | — | Filing → |
| AGIO | SELL | 2018-10-09 | $277K | — | Filing → |